1 month LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Recommendation of “Buy” by AnalystsMarketBeat
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) has earned an average recommendation of “Buy” from the seven ratings firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock wit…
X